Posts Tagged ‘Attention Deficit Hyperactivity’

The United States of Adderall

Friday, September 9th, 2011

“83,776 tons of legal speed were approved for production in 2010 equaling more than half a pound for every man, woman and child in America.”

The Huffington Post – September 9, 2011
by Lawrence Diller, MD

Last week, the Centers for Disease Control (CDC) released analysis of data revealing a major increase in the incidence of attention deficit hyperactivity disorder (ADHD) among children in the United States. The number of children between the ages of five and 17 reported by their parents to “have” ADHD or the non-hyperactive form of the disorder (ADD) had risen from 7 to 9 percent over a decade ending in 2009. Nine percent translates to 4,858,210 children according to 2010 U.S. Census data.

In actuality, the researchers do not know for certain whether these children actually meet criteria for ADHD/ADD. The data is culled from a national telephone survey which asks parents the question, “whether or not a doctor or other health-care provider had ever told them that their child had attention deficit disorder or attention deficit hyperactive disorder, that is, ADD or ADHD.’”

Since there is no biological or psychometric test for ADHD/ADD no one can be certain these children have a definitive neurological condition.

In its extreme form the hyperactivity and impulsivity of ADHD are easy to recognize. But most children are commonly diagnosed with the mild variety which blends seamlessly into the behavior of normal but active or lively children. It is with this mild form where opinions vary widely between professionals. This survey then only measured what parents had been told.

Still the continued rise in the diagnosis and treatment of ADHD/ADD in children is unmistakable. As a long time observer and participant (I prescribe drugs like Ritalin, Adderall and Concerta every day) of this trend, I have watched the 20-year growth of this condition with curiosity and some consternation. I have also been involved in what has been colloquially called “The Ritalin Wars” — an often polemical debate conducted in the media as to whether the widespread use of prescription stimulant drugs (essentially amphetamine) is good or bad for the children of this country.

The upward trend continues. Given the current CDC data, one can safely estimate (based on previously detailed distribution curves) that one of six 11-year-old white boys with medical insurance currently take a stimulant drug at least during the school week. Is this over medication or simply good medical care for children with a previously undiagnosed and untreated condition? What I do know is that we are the only society currently managing our under performing/misbehaving children with drugs to this degree.

While the diagnosis of ADHD/ADD can seem ephemeral, the production of prescription stimulants, whose use is closely tied to the diagnosis, is monitored by the Drug Enforcement Administration (DEA). Since 1996 the annual amount of Ritalin type drugs approved for production by the DEA multiplied 4000 times to 50 million kilograms, and for Adderall 10000 times to 26 million kilograms. In more common terms, 83,776 tons of legal speed were approved for production in 2010 equaling more than half a pound for every man, woman and child in America.

The U.S. is a signatory to a 1972 United Nations treaty monitoring the production and sale of potentially addicting substances. The U.N.’s International Narcotics Control Board (INCB) based in Vienna, monitors the production of legal stimulants worldwide. INCB data shows that in 2009 the U.S., representing 4 percent of the world’s population, produced 88 percent of the world’s legal Ritalin type drugs. Canada uses a third per capita of prescription stimulants compared to the U.S. — Germany, one eighth, the U.K. one twelfth, Japan, one fiftieth.

Read the rest of the article here:  http://www.huffingtonpost.com/larry-diller/overuse-of-prescription-drugs_b_950802.html

« Return to news items


Share

ADHD drugs linked to heart disease and death

Thursday, August 4th, 2011

NaturalNews – August 2, 2011

by Ethan A. Huff

Click image to watch 1 minute video: ADHD—Labeling Normal Kids 'Mentally Ill'

A major study recently published in the journal Pediatrics — and republished by countless other medical and mass media sources — made the bold claim that stimulant drugs like those used to treat attention deficit hyperactivity disorder (ADHD) in children are not linked to cardiovascular events and death. But a recent analysis by Dr. Robert Tozzi writing for FOX News explains that the study was flawed, and that the drugs will cause cardiovascular events or death, especially in individuals with certain conditions.

Like most studies that allege the safety of pharmaceutical drugs, the Pediatrics study was at least partially, if not completely, funded by the drug industry. It was also deliberately constructed in such a way as to artificially minimize the risks associated with stimulant drugs. As a result, its findings ended up mirroring claims long made by the drug industry that stimulant drugs are safe, and that children do not need to be tested for certain conditions prior to being prescribed them.

The study included two groups of children, one taking stimulant drugs, and the other not taking stimulant drugs. The idea was to simply compare the number of heart events between the two groups, and determine whether or not stimulant drugs are associated with an increased risk of heart events and sudden death.

Well, according to Dr. Tozzi, few, if any, of the high-risk children with conditions that would react negatively in the presence of stimulants were placed in the stimulant group. Most parents of children with such conditions, as well as their doctors, would not normally opt for giving stimulants to their high-risk children, and thus the vast majority of these children were placed in the non-stimulant group.

This inherent and obvious flaw completely debunks the credibility of the study. After all, the whole point of it was supposedly to identify whether or not children need to be pre-screened for certain conditions before being prescribed stimulant drugs. With this in mind, it makes sense to actually identify how children with existing conditions respond to stimulant drugs, otherwise the data is meaningless.

It is difficult to say which is worse — testing dangerous drugs on high-risk children, or not testing dangerous drugs on high-risk children and simply declaring that they are  safe (which is what the drug industry basically did in a recent study). One thing is for sure, though. The propositions made in the study that stimulant drugs are safe and do not raise the risk of heart disease and sudden death are patently false. And many children will likely suffer and die as a result of these lies.

To read all international drug regulatory warnings and studies on Ritalin, Adderall, Concerta and other ADHD drugs visit CCHR’s Psychiatric Drug Side Effects Search Engine”

http://www.cchrint.org/psychdrugdangers/drug_warnings.php

http://www.naturalnews.com/033204_ADHD_drugs_death.html

« Return to news items


Share

ADHD review as US expert faces inquiry

Tuesday, July 5th, 2011

The Australian – July 5, 2011

AUSTRALIA’S ADHD guidelines are being redeveloped as a US psychiatrist whose work is heavily cited in existing draft guidelines has been sanctioned by Harvard University for violating conflict-of-interest rules.

Professor Joseph Biederman and two colleagues, Thomas Spencer and Timothy Wilens, were investigated by Harvard after allegedly failing to report to the university millions of dollars they received from drug firms.

Australia’s National Health and Medical Council held off approving the draft guidelines for Attention Deficit Hyperactivity Disorder issued in 2009 as it awaited the outcome of the US conflict-of-interest investigation.

The Boston Globe reported that, in a letter to their colleagues, Professor Biederman, Dr Spencer and Dr Wilens apologised for their “honest” mistakes and said they had been sanctioned.

The National Health and Medical Research Council said yesterday it could not yet assess the impact of the outcome of the Harvard investigation on the scientific literature and said the draft guidelines citing Professor Biederman would remain on its website.

Independently of the Harvard review, the council had appointed a multi-disciplinary panel to develop new clinical practice points to provide clear advice to clinicians and health professionals for the diagnosis and treatment of ADHD, the council said.

The review will be completed in September, but the council was last night unable to provide The Australian with names of the experts involved.

In 2007, Daryl Effron, who chaired the committee that drew up Australia’s draft ADHD guidelines, resigned as chairperson after his ties with pharmaceutical companies that produce ADHD drugs were exposed. He remains on the committee.

About 350,000 Australian children and adolescents are estimated to have ADHD and controversy has been raging about the use of medications such as Ritalin.

Child psychiatrist Professor Jon Jureidini, who argues against the long-term use of stimulant drugs in treating behavioural problems tagged as ADHD, says that the current guidelines rely heavily on Professor Biederman’s work.

http://www.theaustralian.com.au/news/nation/adhd-review-as-us-expert-faces-inquiry/story-e6frg6nf-1226087514583

« Return to news items


Share